Replies to post #3684 on PENNIES TO DOLLARS

[IAMSAM]

Compare charts of these bird flu stocks and tell me what you see. One in there is left to run.

GNBT & AVAN monsters ... PPHM is ready to rock, IMO.

http://moneycentral.msn.com/content/P145206.asp

28 plays on bird flu

Company Mkt Cap YTD % Chg. 2/19/06 Price SS Key product
Chiron (CHIR, news, msgs) $8.5 B 2.1 $45.37 10 Fluvirin, FDA-approved vs. influenza A ***
Gilead Sciences (GILD, news, msgs) 28.1 B 16.9 $61.46 10 Invented Tamiflu, leading drug to lessen H5N1 symptoms
Forest Labs (FRX, news, msgs) 15.2 B 15.3 $46.89 10 Flumadine, FDA-approved to treat influenza A
Endo Pharma (ENDP, news, msgs) 3.9 B -1.5 $29.80 9 Symmetrel, FDA-approved to treat influenza A *
Sanofi-Aventis (SNY, news, msgs) 123 B 0.7 $44.20 8 Rec'd $100M grant from U.S. to develop H5N1 vaccine
MedImmune (MEDI, news, msgs) 8.7 B 2.8 $36.01 7 Flumist, FDA-approved to treat influenza A ***
Roche Holding (RHHBY, news, msgs) 103 B -4 $72.95 Tamiflu, leading H5N1, licensed from Gilead ****
Carrington Labs (CARN, news, msgs) 53.5 M 4.9 $4.96 6 Rec'd $6M grant from U.S. to develop H5N1 vaccine
Novartis (NVS, news, msgs) 127 B 4.2 $54.68 6 Announced plan to develop RNAi therapeutic for H5N1
GlaxoSmithKline (GSK, news, msgs) 144 B 1.5 $51.23 6 Relenza and Flurarix, FDA-approved to treat influenza A ***
Quest Diagnostics (DGX, news, msgs) 10 B 2.6 $52.80 6 DNA test for flu viruses
Acambis (ACAM, news, msgs) 419 M 8.3 $7.83 5 Ampligen, said to amplify effectiveness of Tamiflu
Dynavax Technologies (DVAX, news, msgs) 181 M 44.9 $6.10 5 Imunostimulatory sequence technology to target virus
Vical (VICL, news, msgs) 118 M 0 $4.20 5 Developing DNA-based vaccine vs. H5N1
AVANT Immuno (AVAN, news, msgs) 136 M -2.1 $1.84 4 Announced plans to research H5N1 vaccine
AVI BioPharma (AVII, news, msgs) 333 M 118.8 $7.55 4 Antisense-based therapeutic
Crucell (CRXL, news, msgs) 1.0 B -2.5 $24.96 3 PER.C6 tech used by Sanofi in H5N1 vaccine development
Hemispherx BioPharm (HEB, news, msgs) 169 M 44.7 $3.14 3 Alferon, stimulates Interferon to defend vs. H5N1
Novavax (NVAX, news, msgs) 225 M 19.5 $4.60 3 Technology may help speed H5N1 vaccine development
Quidel (QDEL, news, msgs) 307 M -13.2 $9.34 3 FDA-approved test for influenza A & B
BioCryst Pharm (BCRX, news, msgs) 504 M 13.9 $19.07 2 Peramivir, which may inhibit H5N1 virus
Alnylam Pharm (ALNY, news, msgs) 373 M 5.1 $14.04 2 Announced plan to develop RNAi therapeutic for H5N1
Generex Biotechnology (GNBT, news, msgs) 102 M 95.2 $1.62 2 Developoing anti-H5N1 vaccine w/ Antigen Express tech
CombiMatrix Group (CBMX, news, msgs) 62 M 17.5 $1.61 1 Microarray for typing flu viruses
Qiagen (QGEN, news, msgs) 2.0 B 15 $13.51 DNA test for flu viruses
Sinovac Biotech (SVA, news, msgs) 156 M 3.5 $4.15 Anflu, licensed in China as antiflu vaccine
Peregrine Pharma (PPHM, news, msgs) 254 M 57 $1.46 Tarcivin, chimeric antibody in preclinical trials
NanoViricides (NNVC, news, msgs) 137 $1.92 FluCide I, antiviral targeting H5N1 **

Source: PharmaWeek; MSN Money; company reports; * Proven ineffective against H5N1 in current formulation; ** Trades on Pink Sheets, an unregulated over-the-counter stock exchange; *** Has several additional potential therapies in development ; **** Swiss company that trades on OTC in U.S. in form of ADRs